Adverse events of inactivated COVID-19 vaccine in HIV-infected adults
Abstract This study aims to evaluate the safety of inactivated COVID-19 vaccine among adult people living with HIV (PLWH). In total, 259 PLWH who received at least one dose of inactivated COVID-19 vaccine were enrolled, and post-vaccination adverse events (AEs) were evaluated seven days following ea...
Saved in:
Main Authors: | Songjie Wu, Yubin Zhang, Fangzhao Ming, Shi Zou, Mengmeng Wu, Wei Guo, Weiming Tang, Ke Liang |
---|---|
Format: | article |
Language: | EN |
Published: |
BMC
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/27a2c038879e40c9841cbdbd7bcf23c9 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Thrombotic Adverse Events Reported for Moderna, Pfizer and Oxford-AstraZeneca COVID-19 Vaccines: Comparison of Occurrence and Clinical Outcomes in the EudraVigilance Database
by: Mansour Tobaiqy, et al.
Published: (2021) -
Development of an Inactivated Vaccine against SARS CoV-2
by: Shaikh Terkis Islam Pavel, et al.
Published: (2021) -
Addressing intersectional stigma as a care barrier for HIV-positive people who inject drugs: Design of an RCT in St. Petersburg, Russia
by: Sarah L. Rossi, et al.
Published: (2021) -
Targets and strategies for vaccine development against dengue viruses
by: Wen-Hung Wang, et al.
Published: (2021) -
COVID-19 Vaccination Behavior of People Living with HIV: The Mediating Role of Perceived Risk and Vaccination Intention
by: Li Qi, et al.
Published: (2021)